If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHalo Minerals Regulatory News (HALO)

Share Price Information for Halo Minerals (HALO)

Share Price is delayed by 15 minutes
Get Live Data
9.75    0.00 (0.00%)
Bid:
9.50
Ask:
10.00
Spread: 0.50 (5.263%)
Market Cap: £10.80m
HALO Live PriceLast checked at - London Stock Exchange

Intraday Halo Minerals Share Chart

Holding(s) in Company

9 Oct 2012 11:43

For filings with the FSA include the annex
For filings with issuer exclude the annex
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

Halosource Inc

2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights x
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rights
Other (please specify):
3. Full name of person(s) subject to thenotification obligation: iii The Mako Europe Fund Ltd

Oxburgh Partners LLP

4. Full name of shareholder(s)(if different from 3.):iv
5. Date of the transaction and date onwhich the threshold is crossed orreached: v 8th October 2012
6. Date on which issuer notified: 9th October 2012
7. Threshold(s) that is/are crossed orreached: vi, vii Below 3%
8. Notified details:
A: Voting rights attached to shares viii, ix
Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction Resulting situation after the triggering transaction
NumberofShares NumberofVotingRights Numberof shares Number of votingrights % of voting rights x
Direct Direct xi Indirect xii Direct Indirect
US40638H1086 0 0 2,748,487 100% 3.602%
B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financialinstrument Expirationdate xiii Exercise/ Conversion Period xiv Number of votingrights that may beacquired if theinstrument isexercised/ converted. % of votingrights
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi
Resulting situation after the triggering transaction
Type of financialinstrument Exercise price Expiration date xvii Exercise/Conversion period xviii Number of voting rights instrument refers to % of voting rights xix, xx

Nominal Delta
Total (A+B+C)
Number of voting rights Percentage of voting rights
2,748,487 3.602%
9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

Proxy Voting:
10. Name of the proxy holder:
11. Number of voting rights proxy holder will ceaseto hold:
12. Date on which proxy holder will cease to holdvoting rights:
13. Additional information:
14. Contact name: Oxburgh Partners LLP
15. Contact telephone number: 020 7621 5600
Note: Annex should only be submitted to the FSA not the issuer
Annex: Notification of major interests in sharesxxii
A: Identity of the persons or legal entity subject to the notification obligation
Full name

(including legal form of legal entities)

Oxburgh Partners LLP
Contact address

(registered office for legal entities)

20-22 Mount Row, London W1K 3SF
Phone number & email

02076215600 info@oxburghpartners.com

Other useful information

(at least legal representative for legal persons)

B: Identity of the notifier, if applicable
Full name Jonathan Chamberlain
Contact address As above
Phone number & email As above
Other useful information

(e.g. functional relationship with the person or legal entity subject to the notification obligation)

C: Additional information

Copyright Business Wire 2012

Date   Source Headline
29th Jun 202611:25 amRNSResult of AGM
19th Jun 20267:55 amRNS-RInvestor Meet Company & Crux Investor Videos
17th Jun 20267:00 amRNS-RInitiation of Equity Development Research Coverage
4th Jun 20267:01 amRNSNotice of AGM
4th Jun 20267:00 amRNSAudited Results
29th May 20267:00 amRNSChange of Registered Office
7th May 20267:00 amRNSFiling of Beach Mining Permit Application
1st May 20267:00 amRNSFiling of Maritime Concession Application
8th Apr 20267:00 amRNSAppointment of contractor
2nd Apr 20267:00 amRNSAppointment of Specialised Consultants
31st Mar 20267:00 amRNS-RNew Investor Presentation and Webinar
30th Mar 20268:00 amRNSAdmission to AIM and First Day of Dealings
27th Feb 20197:00 amRNSResult of General Meeting
14th Feb 20197:00 amRNSProposed Disposal and Delisting from AIM
7th Feb 20197:00 amRNSUpdate in Funding Options
20th Dec 20184:30 pmRNSSuspension of trading
3rd Dec 20187:00 amRNSUpdate on Fundraising and Funding Options
26th Oct 20187:00 amRNSTrading Update
2nd Oct 201810:35 amRNSastrea is first bottle certified to reduce lead
27th Sep 20187:00 amRNSInterim Results
10th Sep 20184:04 pmRNSResult of AGM and Total Voting Rights
21st Aug 20186:09 pmRNSFundraise and Change of Adviser
26th Jul 20184:30 pmRNSBlock Listing Return
18th Jul 20187:00 amRNSRetailer Order for astrea
28th Jun 20182:46 pmRNSPosting of Annual Report
13th Jun 20187:00 amRNSAppointment of Joint Broker
9th May 20187:00 amRNSPreliminary Results
12th Apr 20187:00 amRNSResult of Special Meeting
19th Mar 20187:00 amRNSPosting of Circular
12th Mar 20182:00 pmRNSProposed Re-Domicile and Change of Name
26th Jan 20187:00 amRNSBlock Listing Return
12th Jan 20187:00 amRNSSuccessful Commercial Production of Lead Reduction
2nd Jan 20187:00 amRNSResult of AGM
27th Dec 20177:00 amRNSTrading Update
21st Dec 20177:08 amRNSPerfect Water Manufacturing Renews Excl Agreement
15th Dec 20177:01 amRNSPlacing and Subscription
15th Dec 20177:00 amRNSAppointment of Nominated Adviser and Broker
30th Nov 20175:00 pmRNSAIM Disclosure Update
31st Oct 20177:00 amRNSAppointment of Joint Broker
17th Oct 20177:00 amRNSAstrea Advisory Board
22nd Sep 20179:45 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
11th Sep 20177:00 amRNSHalf-year Report
26th Jul 20177:00 amRNSBlock Listing Return
20th Jul 20177:00 amRNSTrading Update
18th Jul 20177:00 amRNSSupply agreement
30th Jun 20174:00 pmRNSAnnual Report and Financial Statements
27th Jun 20173:37 pmRNSGrant of Options
23rd Jun 201711:05 amRNSSecond Price Monitoring Extn
23rd Jun 201711:00 amRNSPrice Monitoring Extension
22nd Jun 20175:46 pmRNSCorrection Director/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.